Kastle Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business
  • Financing Rounds
  • 2
  • Investments
  • 1

Kastle Therapeutics General Information

Description

Developer of biopharmaceutical products designed to help underserved patients with severe diseases. The company is focused on acquiring, developing and commercializing pharmaceuticals for diseases with high unmet medical needs.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • 181 West Madison
  • Suite 3400
  • Chicago, IL 60602
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kastle Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kastle Therapeutics‘s full profile, request access.

Request a free trial

Kastle Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of biopharmaceutical products designed to help underserved patients with severe diseases. The company is focus
Pharmaceuticals
Chicago, IL
00000000 00

00000 00

xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
000000000000000
Atlanta, GA
000 As of 0000
000.00
000000000000 000.00

0000 000

in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat no
000000000000000
Monmouth Junction, NJ
000 As of 0000
000000000 -
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kastle Therapeutics Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arbor Pharmaceuticals Private Equity-Backed Atlanta, GA 000 000.00 000000000000 000.00
0000 000000 Private Debt Financed Monmouth Junction, NJ 000 000000000 -
00000 000000000000 Formerly VC-backed Redwood City, CA 000 00000 000000 - 000 00000
0000000 Formerly VC-backed Emeryville, CA 000 00000 000000 - 000 00000
0000000 0000000000 Corporate Backed or Acquired San Diego, CA 00 00.00 000000&0 00.00
You’re viewing 5 of 11 competitors. Get the full list »

Kastle Therapeutics Patents

Kastle Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20060009410-A1 For treatment of atherosclerosis, metabolic disorders (hyperlipidemia), diabetes, obesity, and/or cardiovascular disease Abandoned 05-May-2004 0000000000 000
US-20100331390-A1 Effects of apolipoprotein b inhibition on gene expression profiles in animals Abandoned 05-May-2004 0000000000 00
US-20150232838-A1 Effects of apolipoprotein b inhibition on gene expression profiles in animals Abandoned 05-May-2004 0000000000
US-20180094260-A1 Effects of apolipoprotein b inhibition on gene expression profiles in animals Abandoned 13-Nov-2002 0000000000
ES-2420914-T3 Antisense modulation of apolipoprotein b expression Active 13-Nov-2002 C12N15/113

Kastle Therapeutics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 03-May-2016 0000000000 0000 Buildings and Property 00000 000000
To view Kastle Therapeutics’s complete investments history, request access »